Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryolipolysis vs ATX-101 for Upper Back Fat
NCT03284034Terminated
- Sponsor
- Northwestern University
- Start
- Nov 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Neobella in localized adiposity (AL) (2 arms), sponsored by Northwestern University. Primary endpoint: Change in fat measurements from baseline to Day 90. Started Nov 2017; status: terminated.
02
Drugs
Neobella
03
Conditions
localized adiposity (AL)
Beyond the preview
Go deeper on NCT03284034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03284034.